Loading clinical trials...
Loading clinical trials...
The Thetis Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight or Obese Volunteers
Conditions
Interventions
Tradipitant
Placebo
Locations
10
United States
Vanda Investigational Site
Los Angeles, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
San Jose, California, United States
Vanda Investigational Site
Tampa, Florida, United States
Vanda Investigational Site
Hamilton, New Jersey, United States
Vanda Investigational Site
New York, New York, United States
Start Date
March 27, 2026
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 20, 2026
NCT07351045
NCT07037459
NCT07508241
NCT07244458
NCT07395687
NCT07311850
Lead Sponsor
Vanda Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions